Article Information
History
- May 13, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Andreas Puyskensa,§,
- Eva Krausea,§,
- Janine Michela,§,
- Micha Nüblingb,
- Heinrich Scheiblauerb,
- Daniel Bourquaina,
- Marica Grossegessea,
- Roman Valusenkoa,
- Viktor Cormanc,
- Christian Drostenc,
- Katrin Zwirglmaierd,
- Roman Wölfeld,
- Constanze Langee,
- Jan Kramere,
- Johannes Friesenf,
- Ralf Ignatiusf,
- Michael Müllerf,
- Jonas Schmidt-Chanasitg,
- Petra Emmerichg,
- Lars Schaadea and
- Andreas Nitschea,*
- aRobert Koch Institute, Centre for Biological Threats and Special Pathogens – Highly Pathogenic Viruses (ZBS 1)
- bTesting Laboratory for In-vitro Diagnostic Medical Devices, Paul-Ehrlich-Institute, Paul-Ehrlich-Straße 51-59, 63225 Langen, Germany
- cCharité – Universitätsmedizin Berlin, Institute of Virology, Rahel-Hirsch-Weg 3, 10117 Berlin, Germany
- dBundeswehr Institute of Microbiology, Neuherbergstraße 11, 80937 Munich, Germany
- eLADR Der Laborverbund Dr. Kramer & Kollegen GbR, Lauenburger Straße 67, 21502 Geesthacht, Germany
- fMVZ Labor28 GmbH, Mecklenburgische Str. 28, 14197 Berlin
- gBernhard Nocht Institute for Tropical Medicine, Arbovirology Department, Bernhard-Nocht-Straße 74, 20359 Hamburg, Germany
- ↵*Corresponding author Prof. Dr. Andreas Nitsche, Robert Koch Institute, Centre for Biological Threats and Special Pathogens – Highly Pathogenic Viruses, Seestraße 10, 13353 Berlin, Germany, Phone: +49 30 187542313, E-Mail: NitscheA{at}rki.de
↵§ These authors contributed equally to this work
Posted May 13, 2021.
Establishment of an evaluation panel for the decentralized technical evaluation of the sensitivity of 31 rapid detection tests for SARS-CoV-2 diagnostics
